Home > National Drug Code (NDC) > carbidopa, levodopa and entacapone

carbidopa, levodopa and entacapone - 55648-787-02 - (carbidopa, levodopa and entacapone)

Alphabetical Index


Drug Information of carbidopa, levodopa and entacapone

Product NDC: 55648-787
Proprietary Name: carbidopa, levodopa and entacapone
Non Proprietary Name: carbidopa, levodopa and entacapone
Active Ingredient(s): 50; 200; 200    mg/1; mg/1; mg/1 & nbsp;   carbidopa, levodopa and entacapone
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of carbidopa, levodopa and entacapone

Product NDC: 55648-787
Labeler Name: Wockhardt Limited
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021485
Marketing Category: NDA AUTHORIZED GENERIC
Start Marketing Date: 20120229

Package Information of carbidopa, levodopa and entacapone

Package NDC: 55648-787-02
Package Description: 100 TABLET, FILM COATED in 1 BOTTLE (55648-787-02)

NDC Information of carbidopa, levodopa and entacapone

NDC Code 55648-787-02
Proprietary Name carbidopa, levodopa and entacapone
Package Description 100 TABLET, FILM COATED in 1 BOTTLE (55648-787-02)
Product NDC 55648-787
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name carbidopa, levodopa and entacapone
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20120229
Marketing Category Name NDA AUTHORIZED GENERIC
Labeler Name Wockhardt Limited
Substance Name CARBIDOPA; ENTACAPONE; LEVODOPA
Strength Number 50; 200; 200
Strength Unit mg/1; mg/1; mg/1
Pharmaceutical Classes Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA],Catechol O-Methyltransferase Inhibitors [MoA],Catechol-O-Methyltransferase Inhibitor [EPC],Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA]

Complete Information of carbidopa, levodopa and entacapone


General Information